JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263286

Human OGFR knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

OGFR KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 3.

View Alternative Names

7 60 protein, HGNC:15768, Met enkephalin receptor, OGFR_HUMAN, Opioid growth factor receptor, Protein 7-60, Zeta Opioid Receptor, Zeta-type opioid receptor

1 Images
Sanger Sequencing - Human OGFR knockout HeLa cell lysate (AB263286)
  • Sanger seq

Unknown

Sanger Sequencing - Human OGFR knockout HeLa cell lysate (AB263286)

Homozygous : 1 bp deletion in exon 3

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 3.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263286-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human OGFR knockout HeLa cell lysate", "number":"AB263286-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263286-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
OGFR
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Opioid Growth Factor Receptor (OGFr) is a protein that significantly influences cellular growth and regulation. Also known as zeta opioid receptor OGFr has an approximate molecular mass of 73 kDa. Researchers find this receptor in various tissues but it is most highly expressed in the brain and eyes. OGFr is a cytoplasmic and nuclear receptor indicating its versatile roles in different cellular compartments. It binds to the Opioid Growth Factor (OGF) also recognized as [Met^5]-enkephalin.
Biological function summary

OGFr regulates cell proliferation impacting both normal tissue maintenance and healing processes. This receptor functions as part of a complex with OGF thereby playing a fundamental part in the negative regulation of cell proliferation. By binding OGF OGFr enters the nucleus and modulates transcription events that influence cell cycle progression. OGFr activity affects diverse cells including those in corneal and epidermal tissues emphasizing its role in cellular homeostasis and repair mechanisms.

Pathways

OGFr integrates into the OGF-OGFr axis a pathway critical for the control of cell growth. This axis plays an important role in the regulation of both DNA synthesis and the cell cycle. OGFr interacts closely with the p16 and p21 proteins which are essential to the pathway's function in cell cycle modulation. The OGF-OGFr axis represents an important biological system that provides a means for cells to regulate their proliferation rate through receptor-ligand interaction.

Researchers have found that OGFr plays a significant part in the growth of various types of cancers such as squamous cell carcinoma and pancreatic cancer. Altered expression or function of OGFr may correlate with abnormal cell proliferation and tumor development. Moreover OGFr's relationship with proteins such as OGF and p21 highlights its potential role in therapeutics for these disease conditions. As targeting this pathway can modulate cell growth it presents a possible avenue for cancer treatment strategies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com